CRISPR-edited tumor-infiltrating lymphocytes are emerging as a promising alternative to CAR T-cell therapy for solid cancers.

Researchers develop IRISeq and EnrichSci to map cellular neighborhoods and analyze rare aging cells in the brain simultaneously.

Deb Hipp is a freelance health and medical writer and editor who lives in Kansas City, Missouri. She is a former investigative reporter with more than 25 years of experience as a journalist and writer ...

IgA nephropathy is a rare condition caused by excessive buildup of immunoglobulin A in the kidneys, slowly but progressively ...

The colorful dots at the center are cytotoxic granules used to destroy infected or cancerous cells. Credit: F. Lemaitre @ ...

IRVINE, Calif., May 13, 2026 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq: ELDN) today reported its first quarter 2026 operating and financial results and provided recent ...

Andes virus, found in South America, is the only currently known hantavirus for which limited human-to-human transmission ...

Probability of Remaining Event-Free at Three Years by Kaplan-Meier Analysis After Achieving Complete Response at Three MonthsFirst and Only ...

Taiho Oncology, Inc. and Taiho Pharmaceutical Co., Ltd., today announced that the U.S. Food and Drug Administration (FDA) has approved INQOVI (decitabine and cedazuridine) plus venetoclax as a ...

Using the BLISS-LN phase 3 study of belimumab, investigators studied biomarker associations with kidney response in lupus nephritis.

The addition of an off-the-shelf pooled stem cell product to a single unit of umbilical cord blood conferred favorable ...

While much is mysterious about the aging process, change over time remains its cornerstone. The biological shifts that ...